Sound View Wealth Advisors Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,938
Closed -$231K 420
2024
Q3
$231K Buy
1,938
+99
+5% +$13.2K 0.02% 379
2024
Q2
$262K Sell
1,839
-76
-4% -$10.1K 0.03% 323
2024
Q1
$246K Sell
1,915
-398
-17% -$47.4K 0.03% 332
2023
Q4
$239K Sell
2,313
-95
-4% -$9.39K 0.03% 341
2023
Q3
$219K Buy
+2,408
New +$212K 0.03% 341
2023
Q1
Sell
-4,626
Closed -$239K 401
2022
Q4
$239K Buy
+4,626
New +$271K 0.03% 341

Other funds holding NVO

Sound View Wealth Advisors Group's NVO Position: Q4 2024 in Review

Sound View Wealth Advisors Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,938 shares — an estimated $231K sold.

Sound View Wealth Advisors Group first reported a position in NVO in Q4 2022 and held it in 6 quarters. The position peaked at $262K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sound View Wealth Advisors Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Sound View Wealth Advisors Group sold 1,938 Novo Nordisk shares in Q4 2024, an estimated $231K.
  • Sound View Wealth Advisors Group first reported a position in Novo Nordisk in Q4 2022 and held it in 6 quarters.
  • Sound View Wealth Advisors Group's Novo Nordisk position peaked at $262K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sound View Wealth Advisors Group's 13F filing for Q4 2024, filed 7 Feb 2025.